Keywords: استنت (ها) everolimus-elute; biodegradable polymers; bioresorbable vascular scaffold; bleeding; drug-eluting stent; percutaneous coronary intervention; stent restenosis; stent thrombosis; 1G-DES; first-generation drug-eluting stent(s); 2G-DES; second-generation drug-eluting stent(s);
مقالات ISI استنت (ها) everolimus-elute (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: استنت (ها) everolimus-elute; CABG; cost effectiveness; PCI; quality of life; stent(s); ASCERT; American College of Cardiology Foundation and the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies; CABG; coronary artery bypass g
Keywords: استنت (ها) everolimus-elute; coronary artery bypass graft; drug-eluting stent(s); meta-analysis; CABG; coronary artery bypass graft surgery; CI; confidence interval; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); HR; hazard ratio; LAD; left anterior descending; LM; lef
Keywords: استنت (ها) everolimus-elute; chronic coronary occlusion; stent reocclusion; CI; confidence interval(s); CTO; chronic total occlusion; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); HR; hazard ratio(s); OR; odds ratio(s); PCI; percutaneous coronary intervention; STAR; s
5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents
Keywords: استنت (ها) everolimus-elute; DES; long-term outcome; newer-generation drug-eluting stent(s); PCI; percutaneous coronary intervention; PROMUS Element everolimus-eluting stent(s); Resolute Integrity zotarolimus-eluting stent(s); DES; drug-eluting stent(s); EES; everolimus-eluting stent
Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease
Keywords: استنت (ها) everolimus-elute; biodegradable polymer-coated stent(s); biolimus-eluting stent(s); everolimus-eluting stent(s); Nobori; Promus; Xience; BES; biolimus-eluting stent(s); BP-BES; biodegradable polymer biolimus-eluting stent(s); DES; drug-eluting stent(s); DP-EES; durable pol
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds
Keywords: استنت (ها) everolimus-elute; bioresorbable scaffold; prognosis; randomized trial; stent; BVS; bioresorbable vascular scaffold(s); DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); ID-TLR; ischemia-driven target lesion revascularization; MI; myocardial infarction; PCI; per
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents
Keywords: استنت (ها) everolimus-elute; bioresorbable vascular scaffold; everolimus-eluting stents; percutaneous coronary intervention; thrombosis; ARD; absolute risk difference; BVS; bioresorbable vascular scaffold(s); EES; everolimus-eluting stent(s); FDA; Food and Drug Administration; ID-TLR
Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory?
Keywords: استنت (ها) everolimus-elute; drug-eluting stent; dual antiplatelet therapy; high bleeding risk patients; in-stent restenosis; stent thrombogenicity; stent thrombosis; BA9; biolimus A9; BMS; bare-metal stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); EES; everoli
Mechanisms of Very Late Bioresorbable Scaffold Thrombosis
Keywords: استنت (ها) everolimus-elute; bioresorbable coronary scaffolds; coronary artery disease; stent; stent thrombosis; 3D; 3-dimensional; ACS; acute coronary syndrome(s); BMS; bare-metal stent(s); BVS; bioresorbable vascular scaffold; DAPT; dual-antiplatelet therapy; DES; drug-eluting sten
Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity
Keywords: استنت (ها) everolimus-elute; everolimus-eluting stent(s); left main disease; percutaneous coronary interventionCABG, coronary artery bypass graft; CTO, chronic total occlusion; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); EuroSCORE, European system for cardiac operat
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis : 3-Year Follow-Up of the RIBS V Clinical Trial
Keywords: استنت (ها) everolimus-elute; drug-eluting balloon(s); drug-eluting stent(s); everolimus-eluting stent(s); in-stent restenosisBMS, bare-metal stent(s); DEB, drug-eluting balloon(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); ISR, in-stent restenosis
Beneficial Effects of a Novel Bioabsorbable Polymer Coating on Enhanced Coronary Vasoconstricting Responses After Drug-Eluting Stent Implantation in Pigs in Vivo
Keywords: استنت (ها) everolimus-elute; inflammation; polymers; stents; Rho-kinase; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); PCI; percutaneous coronary intervention; PDLLA-PCL; poly-dl-lactic acid and polycaprolactone; PLA; polylactic acid; P1+D+ stent; stent with a polylac
Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV
Keywords: استنت (ها) everolimus-elute; drug-eluting stent(s); outcome; percutaneous coronary intervention; very late definite stent thrombosis; BES; biolimus-eluting stent; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); MACE; major adverse card
In-Stent Yellow Plaque at 1 Year After Implantation Is Associated With Future Event of Very Late Stent Failure: The DESNOTE Study (Detect the Event of Very late Stent Failure From the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angiosco
Keywords: استنت (ها) everolimus-elute; coronary stent; intravascular imaging; late stent failure; lipid-rich plaque; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); HR; hazard ratio; SES; sirolimus-eluting stent(s); TLR; target lesion revascularization; VLSF; very late stent fail
Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions)
Keywords: استنت (ها) everolimus-elute; chronic total occlusion; drug-eluting stent; everolimus; percutaneous coronary intervention; ARC; Academic Research Consortium; CK; creatine kinase; CTO; chronic total occlusion; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); MACE; major a
Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison: The BVS-EXAMINATION Study (Bioresorbable Vascular Scaffold-A Clinical
Keywords: استنت (ها) everolimus-elute; ABSORB; everolimus-eluting stent; STEMI; BVS; bioresorbable vascular scaffold(s); CI; confidence interval; DOCE; device-oriented endpoint; EES; everolimus-eluting stent(s); GP; glycoprotein; HR; hazard ratio; MI; myocardial infarction; PCI; percutaneous c
Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revasculariz
Keywords: استنت (ها) everolimus-elute; coronary artery disease; drug-eluting stent; everolimus-eluting stent; long-term follow-up; paclitaxel-eluting stent; randomized trial; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); MI; myocardial infarctio
Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent
Keywords: استنت (ها) everolimus-elute; bioresorbable scaffold; cardiac biomarker; device overlap; periprocedural myocardial infarction; CB; cardiac biomarker; CI; confidence interval; CK; creatine kinase; CK-MB; creatine kinase-myocardial band; EES; everolimus-eluting stent(s); IVUS; intravasc
Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model
Keywords: استنت (ها) everolimus-elute; coronary disease; pathology; stents; thrombosis; BES; biolimus-eluting stent(s); BMS; bare-metal stent(s); CI; confidence interval; DAPI; 4â²,6-diamindino-2-phenylindole; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); SEM; scanning electro
Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With ST Elevation Myocardial Infarction: RACES-MI Trial
Keywords: استنت (ها) everolimus-elute; everolimus-eluting stent(s); primary angioplasty; sirolimus-eluting stent(s); stent thrombosis; ST-segment elevation myocardial infarction; BMS; bare-metal stent(s); CI; confidence interval; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); HR
Three-Year Outcomes After Revascularization With Everolimus- and Sirolimus-Eluting Stents From the SORT OUT IV Trial
Keywords: استنت (ها) everolimus-elute; drug-eluting stent; percutaneous coronary intervention; very late definite stent thrombosis; CI; confidence interval; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); HR; hazard ratio; MI; myocardial infarction; PES; paclitaxel-eluting stent(
4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents : A Report From the RESOLUTE All-Comers Trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Elutin
Keywords: استنت (ها) everolimus-elute; all-comers population; drug-eluting stent(s); everolimus-eluting stent(s); long-term outcomes; Resolute zotarolimus-eluting stent(s)CAD, coronary artery disease; CI, confidence interval; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); EES, ev
Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention : A Pre-Specified Analysis From the PRODIGY Study (PROlonging Dual Antiplatelet Treatment
Keywords: استنت (ها) everolimus-elute; all-comer randomized clinical trial; bare-metal stent(s); everolimus-eluting stent(s); paclitaxel-eluting stent(s); zotarolimus-eluting stent(s)BMS, bare-metal stent(s); CI, confidence interval; CK-MB, creatine kinase myocardial band; DES, drug-eluting st
Everolimus-Eluting Xience V/Promus Versus Zotarolimus-Eluting Resolute Stents in Patients With Diabetes Mellitus
Keywords: استنت (ها) everolimus-elute; diabetes mellitus; drug-eluting stent; everolimus; percutaneous coronary intervention; zotarolimus; CI; confidence interval; DES; drug-eluting stent(s); DM; diabetes mellitus; EES; everolimus-eluting stent(s); HR; hazard ratio; MI; myocardial infarction;
Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent: A Randomized, Controlled, Noninferiority Trial
Keywords: استنت (ها) everolimus-elute; biolimus-eluting stent(s); everolimus-eluting stent(s); percutaneous coronary intervention; BES; biolimus-eluting stent(s); DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); MI; myocardial infarction; PCI; percutaneous coronary intervention; S
Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents: 2-Year Follow-Up of the Rando
Keywords: استنت (ها) everolimus-elute; drug-eluting stent(s); everolimus-eluting stent(s); percutaneous coronary intervention; revascularization; zotarolimus-eluting stent(s); DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); MI; myocardial infarcti
Clinical and Angiographic Outcomes of Patients Treated With Everolimus-Eluting Stents or First-Generation Paclitaxel-Eluting Stents for Unprotected Left Main Disease
Keywords: استنت (ها) everolimus-elute; drug-eluting stent(s); everolimus-eluting stent(s); paclitaxel-eluting stent(s)EES, everolimus-eluting stent(s); MACE, major adverse cardiovascular event(s); MI, myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent
Randomized Trial of Optimal Treatment Strategies for In-Stent Restenosis After Drug-Eluting Stent Implantation
Keywords: استنت (ها) everolimus-elute; angioplasty; coronary disease; stent; BMS; bare-metal stent(s); DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); IQR; interquartile range; ISR; in-stent restenosis; MI; myocardial infarction; SES; sirolimus-eluting stent(s); TLR; target lesio
Primary Endpoint Results of the EVOLVE Trial: A Randomized Evaluation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
Keywords: استنت (ها) everolimus-elute; bioabsorbable polymer; everolimus-eluting stents; PROMUS Element; SYNERGY; CK-MB; creatine kinase-myocardial band; DAPT; dual-antiplatelet therapy; EES; everolimus-eluting stent(s); MI; myocardial infarction; PLGA; poly(DL-lactide-co-glycolide); QCA; quan
Long-Term Comparison of Everolimus- and Sirolimus-Eluting Stents in Patients With Acute Coronary Syndromes
Keywords: استنت (ها) everolimus-elute; acute coronary syndrome(s); drug-eluting stent(s); everolimus-eluting stent(s); sirolimus-eluting stent(s)ACS, acute coronary syndrome(s); CI, confidence interval; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio; MI, myocard
A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients: The TWENTE Trial
Keywords: استنت (ها) everolimus-elute; coronary artery disease; drug-eluting stent; percutaneous coronary intervention; randomized controlled trial; CI; confidence interval; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); MI; myocardial infarction; PCI; percutaneous coronary inte
Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents : Pooled Analysis From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Sten
Keywords: استنت (ها) everolimus-elute; everolimus-eluting stent(s); lesion length; paclitaxel-eluting stent(s); reference vessel diameterBMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); HR, hazard ratio; ID-TLR, ischemia-driven target lesion revascularization; LL,
The Prognostic Utility of the SYNTAX Score on 1-Year Outcomes After Revascularization With Zotarolimus- and Everolimus-Eluting Stents : A Substudy of the RESOLUTE All Comers Trial
Keywords: استنت (ها) everolimus-elute; everolimus-eluting stent(s); resolute zotarolimus-eluting stent(s); SYNTAX score
Everolimus-Eluting Versus Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: The EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) Randomized Trial
Keywords: استنت (ها) everolimus-elute; everolimus; percutaneous coronary intervention; sirolimus; stents; CI; confidence interval; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); LL; late loss; MI; myocardial infarction; MLD; minimal luminal diameter; PCI; percutaneous coronary i